Butyrylcholinesterase anticorps
-
- Antigène Voir toutes Butyrylcholinesterase (BCHE) Anticorps
- Butyrylcholinesterase (BCHE)
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Butyrylcholinesterase est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human BCHE (NP_000046.1).
- Isotype
- IgG
- Top Product
- Discover our top product BCHE Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000 IHC 1:50-1:200 IF 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- Butyrylcholinesterase (BCHE)
- Autre désignation
- BCHE (BCHE Produits)
- Synonymes
- anticorps che, anticorps che1, anticorps bche, anticorps cholinesterase, anticorps CHE1, anticorps CHE2, anticorps E1, anticorps C730038G20Rik, anticorps butyrylcholinesterase L homeolog, anticorps butyrylcholinesterase, anticorps bche.L, anticorps bche, anticorps BCHE, anticorps Bche
- Sujet
- Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
- Poids moléculaire
-
Observed_MW: 68 kDa
Calculated_MW: 68 kDa
- ID gène
- 590
- UniProt
- P06276
- Pathways
- Peptide Hormone Metabolism
-